| Identifier | Protein names | Gene names | Cross reference refseq | Length | Species |
| K7B8S8 | Ca++-dependent secretion activator 2; | CADPS2; | NULL | 1255 | chimpanzee |
| K7D8L9 | Abhydrolase domain containing 16B; | ABHD16B; | NULL | 469 | chimpanzee |
| H2Q2V1 | Uncharacterized protein; Fragment; | LMNTD2; | NULL | 558 | chimpanzee |
| H2QTR5 | Uncharacterized protein; | VNN1; | XP_001169280.1; | 513 | chimpanzee |
| K7B5T0 | ATP citrate lyase; | ACLY; | NULL | 1101 | chimpanzee |
| K7DMQ4 | L1 cell adhesion molecule; | L1CAM; | NULL | 1248 | chimpanzee |
| K7CWX5 | Calcium/calmodulin-dependent protein kinase II gamma; | CAMK2G; | NULL | 504 | chimpanzee |
| K7D9E8 | EF-hand domain family, member D2; | EFHD2; | NULL | 240 | chimpanzee |
| H2Q2X7 | NAD(P)(+)--arginine ADP-ribosyltransferase; EC 2.4.2.31; Mono(ADP-ribosyl)transferase; | ART1; | XP_521725.1; | 327 | chimpanzee |
| H2Q336 | Uncharacterized protein; | NLRP14; | XP_521822.2; | 1093 | chimpanzee |
| H2QTP2 | Uncharacterized protein; | NKAIN2; | XP_001152524.2; | 208 | chimpanzee |
| H2QN81 | Uncharacterized protein; | PARP15; | XP_001167586.2; | 678 | chimpanzee |
| H2R7D4 | Uncharacterized protein; | CLPSL1; | XP_001172513.1; | 120 | chimpanzee |
| H2QN64 | Uncharacterized protein; | HGD; | XP_001164938.1; | 445 | chimpanzee |
| H2QG49 | Uncharacterized protein; | NFKBID; | XP_003316377.1; | 465 | chimpanzee |
| H2RED1 | Uncharacterized protein; | LCE6A; | XP_003308527.1; | 80 | chimpanzee |
| K7AL59 | Inositol 1,4,5-trisphosphate receptor, type 2; | ITPR2; | NULL | 2701 | chimpanzee |
| H2PYD9 | Uncharacterized protein; | AIM1L; | NULL | 616 | chimpanzee |
| H2REH3 | Uncharacterized protein; | ZNF90; | NULL | 112 | chimpanzee |
| H2PYR8 | Uncharacterized protein; | TMCO2; | XP_001172267.1; | 182 | chimpanzee |
UrgentMab™: Thinking is cheap. Test your ideas, fast and furious. |
 |
|
Custom monoclonal antibody in one month. As low as $200-300 per antigen. |
|
A product of Absolution |
|
SEAL™: Today's out-of-reach protein targets made accessible. |
|
|
Same budget, 5-10 times more antibodying SEAL your protein. Successes too. |
|
A product of Absolution |
|
PETAL™: Fast and high throughput antibody discover platform. |
 |
|
Deliver customized antibody in two weeks at price of category antibody Proteome-scale antibody discovery for any organism or proteome Biomarker discovery for biological processes or human diseases |
|
A product of Absolution |
|
AbFocus™: Target all the modification sites of your protein, affordably. |
|
|
Test them with a panel of AbFocus antibodies It is so affordable that you can focus on testing, not guessing |
|
A product of Absolution |
Mabome™: Catch the antibody gold rush.? Lead the next omics revolution. |
|
|
First-ever antibody proteomics technology. High quality monoclonal antibodies for your favorite proteome. As low as $19/monoclonal antibody |
|
A product of Absolution |
AbTarget™: Performing antibody for your proteome.? Guaranteed |
|
|
Fast, efficient monoclonal antibody development for proteins in a proteome Pay for successful antibodies only |
|
A product of Absolution |
AbProfile™: Discover an array of unbiased differences.? Proteome-scale |
|
|
50,000 monoclonal antibodies on an array.100 times more content. Differential profiling thousands of cell surface receptorsand plasma proteins |
|
A product of Absolution |
|
SMAL™:?All big things have a SMAL beginning. |
|
|
High success rate for mAb generation Deliver a panel of high affinity mAbs Flexible and optional fee structure for minimizing risks |
|
A product of Absolution |
AbX™: X=anything.? Find your antibody within |
|
|
currently 7species.?200,000 mAbs.70,000 proteins 3 new organisms are being AbXed/day Pre-made anti-peptide mAbs against all proteins in nature. |
|
A product of AbStore |
AbStop™: The last stop of antibody development. The most successful stop. |
|
|
Pre-designed antibody packages against high value targets The most aggressive and comprehensive protein targeting Best for diagnostics and therapeutic antibody development |
|
A product of AbStore |